Comparable stake leader
Jordan G. Naydenov
SEC ownership of CytoDyn Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001175680.
Disclosed value leader
Jordan G. Naydenov
Comparable rows
0/24
Latest evidence
30 Jun 2026
- Public ticker
- CYDY on OTC
- Parsed ownership sources
-
3/4/5 and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Jordan G. Naydenov
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001175680
- Issuer location
- Vancouver, WA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of CytoDyn Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Jordan G. Naydenov
Disclosed value leader
Jordan G. Naydenov
Comparable rows
0/24
Latest evidence
30 Jun 2026
3/4/5
13F
Highest disclosed value: $5,992,658
24 rows are not safely comparable across share classes.
Showing 1-8 of 24 holder rows.
Quick read
Jordan G. Naydenov has the largest disclosed position value at $5.99M.
0 of 24 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Jordan G. Naydenov's linked filing trail.
Disclosed position value
Top 5
Jordan G. Naydenov
$5.99M
Scott A. Kelly
$2.22M
Arvin Cyrus Arman
$811K
Chris P. Recknor
$537.6K
Nitya G. Ray
$375.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 24 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jordan G. Naydenov |
3/4/5
Director
|
—
mixed-class rows
|
$5,992,658
8,215,211 shares
mixed-class rows
|
— | 18 Oct 2021 |
| Scott A. Kelly |
3/4/5
CMO
|
—
mixed-class rows
|
$2,224,834
5,281,884 shares
mixed-class rows
|
— | 28 Nov 2022 |
| Arvin Cyrus Arman |
3/4/5
President
|
—
mixed-class rows
|
$811,001
1,516,116 shares
mixed-class rows
|
— | 13 Feb 2023 |
| Chris P. Recknor |
3/4/5
Officer
|
—
class O/S missing
|
$537,560
716,746 shares
|
— | 31 Mar 2022 |
| Nitya G. Ray |
3/4/5
Chief Technology Officer
|
—
class O/S missing
|
$375,068
500,090 shares
|
— | 15 Nov 2022 |
| Tanya Durkee Urbach |
3/4/5
Director
|
—
mixed-class rows
|
$121,585
1,536,498 shares
mixed-class rows
|
— | 20 Mar 2026 |
| Diversified Trust Co |
13F
Company
|
—
class O/S missing
|
$10,934
45,790 shares
|
— | 30 Jun 2026 |
| Williams Jones Wealth Management, LLC. |
13F
Company
|
—
class O/S missing
|
$10,746
45,001 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 28 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 20 reporting-owner rows connected to CytoDyn Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
20
Largest Forms 3/4/5 holder
Jordan G. Naydenov
Net 12M change
$0
Latest report
20 Mar 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jordan G. Naydenov | Director | $5,992,658 | Mixed | 18 Oct 2021 | ||
| Scott A. Kelly | Cmo | $2,224,834 | Mixed | 28 Nov 2022 | ||
| Arvin Cyrus Arman | President | $811,001 | Mixed | 13 Feb 2023 | ||
| Chris P. Recknor | Officer | $537,560 | Mixed | 31 Mar 2022 | ||
| Nitya G. Ray | Chief Technology Officer | $375,068 | Mixed | 15 Nov 2022 | ||
| Tanya Durkee Urbach | Director | $121,585 | Mixed | 20 Mar 2026 | ||
| Tyler Blok | Chief Legal Officer | $188 | Mixed | 20 Mar 2026 | ||
| Ryan Dunlap | Director | Mixed | 20 Mar 2026 | |||
| Nader Pourhassan | President & CEO, Director | Mixed | 18 Oct 2021 | |||
| Robert E. Hoffman | Chief Financial Officer | Mixed | 20 Mar 2026 | |||
| Gordon A. Gardiner | Director | Mixed | 24 Nov 2021 | |||
| Alan P. Timmins | Director | Mixed | 24 Nov 2021 | |||
| Samir R. Patel | Director | Mixed | 24 Nov 2021 | |||
| Mitchell Cohen | Interim CFO | Mixed | 01 Feb 2024 | |||
| Karen J. Brunke | Director | Mixed | 20 Mar 2026 | |||
| Lishomwa C. Ndhlovu | Director | Mixed | 20 Mar 2026 | |||
| Jacob P. Lalezari | Chief Executive Officer | Mixed | 20 Mar 2026 | |||
| Harish Seethamraju | Director | Mixed | 24 Nov 2021 | |||
| Stephen M. Simes | Director | Mixed | 20 Mar 2026 | |||
| Antonio Migliarese | Cfo | Mixed | 03 Jan 2024 |
Recent insider transactions for CytoDyn Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Tanya Durkee Urbach | CYDY | Non-qualified stock option (right to buy) | Award | 574,385 | 574,385 | 20 Mar 2026 | Direct | |||
| Stephen M. Simes | CYDY | Non-qualified stock option (right to buy) | Award | 574,385 | 574,385 | 20 Mar 2026 | Direct | |||
| Lishomwa C. Ndhlovu | CYDY | Non-qualified stock option (right to buy) | Award | 574,385 | 574,385 | 20 Mar 2026 | Direct | |||
| Jacob P. Lalezari | CYDY | Non-qualified stock option (right to buy) | Award | 4,874,691 | 4,874,691 | 20 Mar 2026 | Direct | |||
| Robert E. Hoffman | CYDY | Non-qualified stock option (right to buy) | Award | 4,874,691 | 4,874,691 | 20 Mar 2026 | Direct | |||
| Ryan Dunlap | CYDY | Non-qualified stock option (right to buy) | Award | 574,385 | 574,385 | 20 Mar 2026 | Direct | |||
| Karen J. Brunke | CYDY | Non-qualified stock option (right to buy) | Award | 574,385 | 574,385 | 20 Mar 2026 | Direct | |||
| Tyler Blok | CYDY | Non-qualified stock option (right to buy) | Award | 3,249,794 | 3,249,794 | 20 Mar 2026 | Direct |
* marks a reported price that did not pass the local price check.